Outcome of the Board Meeting held today, i.e. Thursday, 17th September, 2026

HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 Date: 17th September, 2026 BSE Limited Phiroze Jeejeebhoy Tower, Dalal Street, Mumbai – 400001. Dear Sir/Ma’am, Sub: Outcome of Board Meeting held today i.e., Thursday, 17th September, 2026 Ref: Scrip Code: 524590 | Symbol: HEMORGANIC | ISIN: INE422G01015 Pursuant to the Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors at its meeting held today i.e., Thursday, 17th September, 2026 at the registered office of the company situated at Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350, which commenced at 0 : P.M. and concluded at 0 :30 P.M, inter alia, considered and took note of the receipt of 2nd tranche of consideration of convertible warrants amounting to Rs. 2,76,25,000/- (Rupees Two Crores Seventy-Six L5a4kh5 Twenty- Five Thousand6 Only) from the respective allottees belonging to the “Non-Promoter” category as mention in Annexure-1, in accordance with the applicable provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. Upon receipt of the remaining consideration and valid exercise and conversion of the 34,00,000 outstanding warrants into an equivalent number of Equity Shares, the paid-up Equity Share Capital of the Company would increase from ₹3,46,59,000/- comprising 34,65,900 Equity Shares of ₹10/- each to ₹6,86,59,000/- comprising 68,65,900 Equity Shares of ₹10/- each, subject to the applicable statutory and regulatory requirements and completion of the conversion and allotment process in accordance with the provisions of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. You are requested to take the same on record. FOR, HEMO ORGANIC LIMITED VISHWAMBAR KAMESHWAR SINGH MANAGING DIRECTOR DIN: 09822587 HEMO ORGANIC LIMITED CIN - L24231GJ1992PLC018224 Address: Shop 1 to 3, First floor, Piyu Apartment Opp Electricity Sub Station & Mahesh Nagar, Nr. Radhika Chambers & Jay Amarnath Society, Nikol Gam Road, Uttamnagar, Ahmedabad, Gujarat, India – 382 350 Email ID: hemoorganic@gmail.com Website: www.hemoorganic.co Ph. No. 8238557874 ANNEXURE – I (LIST OF ALLOTTEES FOR CONVERTIBLE WARRANTS ON PREFERENTIAL BASIS) Sr. Name of the Allottee(s) No. of 25% 2nd Tranche of No. Convertible Consideration Consideration Warrants (Amount in Rs.) (Amount in Rs.) allotted 1. Vacro Enterprises Private 17,00,000 53,12,500 1,38,12,500 Limited 2. Qmin Realities Private 17,00,000 53,12,500 1,38,12,500 Limited Total 34,00,000 1,06,25,000 2,76,25,000